Stock listing
OTC:PTPI Petros Pharmaceuticals Inc Stock
Follow Petros Pharmaceuticals Inc into a list and get an email when it puts out news.
Share price · OTC:PTPI
$0.0021 USD 0.0000 (0.0%)
Close on Nov 20, 2026
- Day range
- $0.0015 – $0.0021 USDNov 20, 2026
- Volume
- 361 sharesNov 20, 2026
- Market cap
- $88,982 USDAt the close on Nov 20, 2026 · price × 42.37M shares outstanding
- 52-week range
- $0.0015 – $0.0160 USDLowest and highest trades, Nov 21, 2025 – Nov 20, 2026
- Traded on an average day
- $457 USDMedian day 72,850 shares · 1 day with no trades · last 3 months, Aug 20, 2026 – Nov 20, 2026

Daily closes
Last 3 months, Aug 20, 2026 – Nov 20, 2026 · OTC:PTPI · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $0.0021 | 0.0000 | 0.0% | $0.0015 | $0.0021 | $0.0015 | 361 | |
| $0.0021 | +0.0001 | +5.0% | $0.0023 | $0.0023 | $0.0021 | 189,156 | |
| $0.0020 | -0.0010 | -33.3% | $0.0020 | $0.0030 | $0.0020 | 57,400 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 56,100 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 19,800 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 28,100 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 6,200 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 112,200 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 1,100 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 142,100 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 120,000 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 170,200 | |
| $0.0030 | +0.0010 | +50.0% | $0.0020 | $0.0030 | $0.0020 | 33,500 | |
| $0.0020 | -0.0020 | -50.0% | $0.0030 | $0.0030 | $0.0020 | 90,600 | |
| $0.0040 | +0.0020 | +100.0% | $0.0020 | $0.0040 | $0.0020 | 729,900 | |
| $0.0020 | 0.0000 | 0.0% | $0.0020 | $0.0020 | $0.0020 | 387,900 | |
| $0.0020 | 0.0000 | 0.0% | $0.0020 | $0.0020 | $0.0020 | 150,700 | |
| $0.0020 | 0.0000 | 0.0% | $0.0020 | $0.0020 | $0.0020 | 60,000 | |
| $0.0020 | 0.0000 | 0.0% | $0.0020 | $0.0020 | $0.0020 | 6,500 | |
| $0.0020 | 0.0000 | 0.0% | $0.0020 | $0.0020 | $0.0020 | 349,700 | |
| $0.0020 | 0.0000 | 0.0% | $0.0020 | $0.0030 | $0.0020 | 172,300 | |
| $0.0020 | 0.0000 | 0.0% | $0.0020 | $0.0020 | $0.0020 | 109,700 | |
| $0.0020 | -0.0010 | -33.3% | $0.0030 | $0.0030 | $0.0020 | 89,600 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 0 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 159,200 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 141,100 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 22,000 | |
| $0.0030 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0030 | 32,900 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0040 | $0.0030 | 271,600 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0040 | $0.0030 | 185,000 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0040 | $0.0030 | 265,000 | |
| $0.0030 | 0.0000 | 0.0% | $0.0030 | $0.0030 | $0.0030 | 7 | |
| $0.0030 | -0.0010 | -25.0% | $0.0030 | $0.0040 | $0.0030 | 113,500 | |
| $0.0040 | 0.0000 | 0.0% | $0.0030 | $0.0040 | $0.0030 | 43,500 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 33,500 | |
| $0.0040 | +0.0010 | +33.3% | $0.0030 | $0.0040 | $0.0030 | 122,200 | |
| $0.0030 | -0.0040 | -57.1% | $0.0040 | $0.0050 | $0.0020 | 1,177,100 | |
| $0.0070 | +0.0020 | +40.0% | $0.0040 | $0.0070 | $0.0040 | 98,900 | |
| $0.0050 | +0.0010 | +25.0% | $0.0040 | $0.0050 | $0.0040 | 64,900 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 27,100 | |
| $0.0040 | -0.0010 | -20.0% | $0.0050 | $0.0050 | $0.0040 | 13,000 | |
| $0.0050 | +0.0010 | +25.0% | $0.0050 | $0.0060 | $0.0040 | 78,200 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 1 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 400 | |
| $0.0040 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0040 | 51,200 | |
| $0.0040 | -0.0020 | -33.3% | $0.0040 | $0.0050 | $0.0040 | 28,900 | |
| $0.0060 | 0.0000 | 0.0% | $0.0060 | $0.0060 | $0.0050 | 67,500 | |
| $0.0060 | +0.0010 | +20.0% | $0.0050 | $0.0060 | $0.0040 | 279,000 | |
| $0.0050 | -0.0010 | -16.7% | $0.0060 | $0.0060 | $0.0050 | 32,300 | |
| $0.0060 | 0.0000 | 0.0% | $0.0070 | $0.0080 | $0.0060 | 289,800 | |
| $0.0060 | -0.0010 | -14.3% | $0.0060 | $0.0070 | $0.0060 | 6,100 | |
| $0.0070 | -0.0010 | -12.5% | $0.0070 | $0.0070 | $0.0060 | 48,100 | |
| $0.0080 | +0.0020 | +33.3% | $0.0080 | $0.0080 | $0.0060 | 139,500 | |
| $0.0060 | 0.0000 | 0.0% | $0.0080 | $0.0080 | $0.0060 | 39,800 | |
| $0.0060 | +0.0010 | +20.0% | $0.0060 | $0.0100 | $0.0050 | 182,800 | |
| $0.0050 | 0.0000 | 0.0% | $0.0040 | $0.0100 | $0.0040 | 155,500 | |
| $0.0050 | 0.0000 | 0.0% | $0.0050 | $0.0050 | $0.0040 | 108,800 | |
| $0.0050 | +0.0010 | +25.0% | $0.0050 | $0.0050 | $0.0040 | 161,300 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 117,500 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 1,400 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0050 | $0.0040 | 65,700 | |
| $0.0040 | -0.0010 | -20.0% | $0.0040 | $0.0040 | $0.0040 | 5,100 | |
| $0.0050 | +0.0010 | +25.0% | $0.0040 | $0.0050 | $0.0040 | 5,300 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0040 | $0.0040 | 78,800 | |
| $0.0040 | 0.0000 | 0.0% | $0.0040 | $0.0050 | $0.0040 | 501,000 | |
| $0.0040 | 0.0000 | 0.0% | $0.0030 | $0.0040 | $0.0030 | 5,600 |
Splits
2 splits since 2022 · OTC:PTPI · every price before a split is adjusted for it
| Day | Ratio | What |
|---|---|---|
| 1-for-25 | Consolidation | |
| 1-for-10 | Consolidation |
- Ticker
- OTC:PTPI
- Asset type
- Stock
- Exchange
- OTC
- Currency
- USD
Petros Pharmaceuticals Inc on 6ix
- Decks
- 1 deck · latest Sep 7, 2023
Valuation
Statements: 4 quarters to Jun 30, 2026 · price Nov 20, 2026
- Enterprise value
- −$3.40M USD
- P/E
- Loss
- EV/sales
- No revenue
- EV/EBITDA
- No depreciation figure on 6ix yet
- Price/book
- 0.1×
- Gross margin
- No revenue
- Operating margin
- No revenue
- Net margin
- No revenue
- Debt to equity
- 0.0×
- Beta vs S&P 500
- 0.60
Team and board
| Director | Role |
|---|---|
| Bruce Bernstein | Board of Directors |
| Josh Silverman | Vice-Chairman of the Board |
| Wayne Walker | Board of Directors |
Events
| Quarter | Results | Share move |
|---|---|---|
| Q3 2025 | Nov 13, 2025 | −5.6% |
| Q2 2025 | Aug 14, 2025 | +3.3% |
| Q1 2025 | May 15, 2025 | −5.0% |
| Q4 2024 | Mar 31, 2025 | −2.3% |
| Q3 2024 | Nov 13, 2024 · After close | −4.6% |
| Q2 2024 | Aug 14, 2024 · After close | +8.0% |
| Q1 2024 | May 15, 2024 · After close | +6.2% |
| Q3 2023 | Nov 15, 2023 · After close | −6.0% |
| Q2 2023 | Aug 30, 2023 | −6.6% |
| Q4 2022 | Mar 31, 2023 | −5.1% |
All 18 quarters
| Quarter | Results | Share move |
|---|---|---|
| Q3 2022 | Nov 14, 2022 | +1.9% |
| Q2 2022 | Aug 12, 2022 | +4.5% |
| Q1 2022 | May 16, 2022 | −5.3% |
| Q4 2021 | Mar 31, 2022 | −9.9% |
| Q3 2021 | Nov 15, 2021 | −20.6% |
| Quarter to Jun 30, 2021 | Aug 16, 2021 | −17.2% |
| Quarter to Mar 31, 2021 | May 14, 2021 | +6.1% |
| Quarter to Dec 31, 2020 | Mar 31, 2021 | −1.1% |
Decks
| Deck | Kind | Slides | Date |
|---|---|---|---|
| Investor Presentation (September 2023) | Investor deck | 10 slides | Sep 7, 2023 |
Financials
Annual, in USD
Income statement
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Revenue | 5.11M | 5.82M | 5.99M | 7.81M | 9.56M | |
| Cost of revenue | 1.21M | 1.63M | 2.29M | 1.60M | 4.05M | |
| Gross profit | 3.90M | 4.19M | 3.70M | 6.21M | 5.51M | |
| Research and development | 2.62M | 2.41M | 1.74M | 1.79M | 459.6K | |
| Selling, general and administrative | 4.64M | 4.63M | 9.26M | 12.2M | 15.6M | 15.7M |
| Operating income | -4.64M | -4.63M | -13.6M | -19.9M | -18.0M | -17.3M |
| Depreciation and amortization | 2.83M | 3.28M | 5.60M | 6.88M | 6.66M | |
| EBITDA | -1.80M | -10.3M | -14.3M | -11.2M | -10.6M | |
| Interest expense | 560.9K | 536.1K | 596.0K | 368.7K | 3.05M | |
| Income before tax | -4.50M | -705.2K | -8.16M | -20.0M | -8.99M | -22.0M |
| Income tax | 0 | 0 | 0 | 0 | -1.43M | |
| Net income | 1.91M | -14.3M | -8.16M | -20.0M | -8.99M | -20.6M |
| Earnings per share, basic | -1.56 | -83.47 | -6.35 | -9.68 | -8.25 | -3.85 |
| Earnings per share, diluted | -1.56 | -83.47 | -6.35 | -9.68 | -8.25 | -3.85 |
Balance sheet
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash and equivalents | 5.14M | 1.72M | 13.3M | 9.43M | 23.8M | 17.1M |
| Receivables | 416.1K | 2.23M | 2.11M | 2.46M | 5.15M | |
| Inventory | 1.35M | 1.61M | 1.82M | 519.6K | 760.5K | |
| Current assets | 5.16M | 7.29M | 20.4M | 14.7M | 30.5M | 25.9M |
| Property, plant and equipment | 22.9K | 29.0K | 39.2K | 49.4K | 64.3K | |
| Total assets | 5.16M | 10.6M | 33.8M | 32.4M | 67.4M | 69.9M |
| Accounts payable | 83.9K | 764.3K | 1.71M | 1.81M | 4.56M | |
| Current liabilities | 2.29M | 18.0M | 10.8M | 7.07M | 31.0M | 41.9M |
| Total debt | 7.18M | |||||
| Total liabilities | 2.29M | 18.1M | 21.3M | 15.7M | 31.8M | 52.4M |
| Shareholders' equity | 2.87M | -7.47M | 12.1M | 16.7M | 35.5M | 17.5M |
| Shares outstanding | 42.3M | 421.1K | 2.99M | 2.08M | 2.07M | 9.71M |
Cash flow
| Line | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 |
|---|---|---|---|---|---|---|
| Cash from operations | -6.73M | -2.60M | -7.63M | -12.8M | -11.9M | -15.3M |
| Capital spending | -24.6K | -4.63K | ||||
| Free cash flow | -2.63M | -15.3M | ||||
| Cash from investing | -24.6K | -4.63K | ||||
| Cash from financing | 8.16M | -7.00M | 11.5M | -1.62M | 18.6M | 30.3M |
| Change in cash | 1.43M | -9.63M | 3.91M | -14.4M | 6.71M | 15.0M |
Filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 8-K · Current report | Sep 30, 2026 | Management or board change | SEC |
| 10-Q · Quarterly report | Aug 13, 2026 | Quarterly report | SEC |
| 3 · Initial statement of ownership | Jun 25, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 18, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jun 8, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jun 5, 2026 | Insider trade | SEC |
| 8-K · Current report | Jun 5, 2026 | Management or board change | SEC |
| 10-Q · Quarterly report | May 13, 2026 | Quarterly report | SEC |
Show 200 filings
| Filing | Date | Type | Filed with |
|---|---|---|---|
| 10-K · Annual report | Apr 15, 2026 | Annual report | SEC |
| NT 10-K · Late filing notice | Mar 31, 2026 | Explanation request | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 17, 2026 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 6, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 8-K · Current report | Jan 2, 2026 | Management or board change | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 4 · Change in ownership | Jan 2, 2026 | Insider trade | SEC |
| 25-NSE | Nov 20, 2025 | Other filings | SEC |
| 10-Q · Quarterly report | Nov 13, 2025 | Quarterly report | SEC |
| 8-K · Current report | Nov 7, 2025 | Current report | SEC |
| 8-K · Current report | Sep 5, 2025 | Current report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Aug 15, 2025 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Aug 14, 2025 | Quarterly report | SEC |
| 8-K · Current report | Jun 20, 2025 | Current report | SEC |
| 8-K · Current report | May 21, 2025 | Current report | SEC |
| 10-Q · Quarterly report | May 15, 2025 | Quarterly report | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | May 15, 2025 | Big-stake notice | SEC |
| 8-K · Current report | May 2, 2025 | Current report | SEC |
| 8-K · Current report | Apr 11, 2025 | Management or board change | SEC |
| 8-K · Current report | Apr 9, 2025 | Current report | SEC |
| 10-K · Annual report | Mar 31, 2025 | Annual report | SEC |
| DEF 14A · Proxy statement | Mar 18, 2025 | Meeting notice | SEC |
| UPLOAD · Letter from the SEC | Mar 17, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Mar 14, 2025 | Other filings | SEC |
| PRER14A | Mar 14, 2025 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Mar 13, 2025 | Other filings | SEC |
| PRE 14A · Preliminary proxy statement | Mar 7, 2025 | Meeting notice | SEC |
| SCHEDULE 13G · Big-stake notice | Feb 26, 2025 | Big-stake notice | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 4 · Change in ownership | Feb 21, 2025 | Insider trade | SEC |
| 8-K · Current report | Feb 21, 2025 | Material contract | SEC |
| 424B4 · Prospectus | Feb 19, 2025 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Feb 18, 2025 | Other filings | SEC |
| S-1MEF · Registration of more shares for the same offering | Feb 14, 2025 | Offer document | SEC |
| CORRESP · Letter to the SEC | Feb 14, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 14, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 14, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 14, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Feb 14, 2025 | Offer document | SEC |
| SCHEDULE 13G/A · Big-stake notice, amended | Feb 13, 2025 | Big-stake notice | SEC |
| CORRESP · Letter to the SEC | Feb 13, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Feb 13, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Feb 12, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 11, 2025 | Other filings | SEC |
| CORRESP · Letter to the SEC | Feb 11, 2025 | Other filings | SEC |
| S-1/A · Registration statement, amended | Feb 10, 2025 | Offer document | SEC |
| UPLOAD · Letter from the SEC | Jan 30, 2025 | Other filings | SEC |
| S-1 · Registration statement | Jan 24, 2025 | Offer document | SEC |
| 8-K · Current report | Jan 24, 2025 | Material contract | SEC |
| 8-K · Current report | Dec 16, 2024 | Current report | SEC |
| 8-K · Current report | Nov 21, 2024 | Meeting outcome | SEC |
| DEFA14A · Additional proxy material | Nov 18, 2024 | Meeting notice | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 14, 2024 | Big-stake notice | SEC |
| 10-Q · Quarterly report | Nov 13, 2024 | Quarterly report | SEC |
| SC 13G/A · Big-stake notice, amended | Nov 13, 2024 | Big-stake notice | SEC |
| ARS · Annual report to shareholders | Oct 25, 2024 | Annual report | SEC |
| DEF 14A · Proxy statement | Oct 25, 2024 | Meeting notice | SEC |
| 8-K · Current report | Oct 18, 2024 | Management or board change | SEC |
| 8-K · Current report | Oct 17, 2024 | Material contract | SEC |
| PRE 14A · Preliminary proxy statement | Oct 15, 2024 | Meeting notice | SEC |
| 8-K · Current report | Oct 4, 2024 | Management or board change | SEC |
| 8-K · Current report | Sep 19, 2024 | Current report | SEC |
| 10-Q · Quarterly report | Aug 14, 2024 | Quarterly report | SEC |
| 10-K/A · Annual report, amended | May 31, 2024 | Annual report | SEC |
| EFFECT · Notice that a registration is effective | May 21, 2024 | Other filings | SEC |
| CORRESP · Letter to the SEC | May 17, 2024 | Other filings | SEC |
| 10-Q · Quarterly report | May 15, 2024 | Quarterly report | SEC |
| UPLOAD · Letter from the SEC | May 9, 2024 | Other filings | SEC |
| S-3 · Registration statement | May 3, 2024 | Offer document | SEC |
| 10-K · Annual report | Apr 1, 2024 | Annual report | SEC |
| 8-K · Current report | Mar 22, 2024 | Material contract | SEC |
| SC 13G · Big-stake notice | Feb 14, 2024 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 6, 2024 | Big-stake notice | SEC |
| 8-K · Current report | Jan 12, 2024 | Current report | SEC |
| 8-K · Current report | Dec 29, 2023 | Meeting outcome | SEC |
| 8-K · Current report | Dec 28, 2023 | Management or board change | SEC |
| 4 · Change in ownership | Dec 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 26, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Dec 26, 2023 | Insider trade | SEC |
| ARS · Annual report to shareholders | Nov 30, 2023 | Annual report | SEC |
| DEF 14A · Proxy statement | Nov 30, 2023 | Meeting notice | SEC |
| 10-Q · Quarterly report | Nov 15, 2023 | Quarterly report | SEC |
| NT 10-Q · Late filing notice | Nov 15, 2023 | Explanation request | SEC |
| 8-K · Current report | Oct 2, 2023 | Current report | SEC |
| 424B3 · Prospectus | Sep 19, 2023 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Sep 19, 2023 | Other filings | SEC |
| CORRESP · Letter to the SEC | Sep 15, 2023 | Other filings | SEC |
| S-3/A · Registration statement, amended | Sep 15, 2023 | Offer document | SEC |
| 8-K · Current report | Sep 15, 2023 | Management or board change | SEC |
| DEF 14A · Proxy statement | Aug 25, 2023 | Meeting notice | SEC |
| UPLOAD · Letter from the SEC | Aug 16, 2023 | Other filings | SEC |
| 8-K · Current report | Aug 15, 2023 | Current report | SEC |
| PRE 14A · Preliminary proxy statement | Aug 15, 2023 | Meeting notice | SEC |
| 10-Q · Quarterly report | Aug 14, 2023 | Quarterly report | SEC |
| S-3 · Registration statement | Aug 11, 2023 | Offer document | SEC |
| D | Jul 21, 2023 | Other filings | SEC |
| 8-K · Current report | Jul 13, 2023 | Material contract | SEC |
| 10-Q · Quarterly report | May 15, 2023 | Quarterly report | SEC |
| 4 · Change in ownership | Apr 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 28, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 12, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Apr 12, 2023 | Insider trade | SEC |
| 10-K · Annual report | Mar 31, 2023 | Annual report | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 8, 2023 | Big-stake notice | SEC |
| 4 · Change in ownership | Jan 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 25, 2023 | Insider trade | SEC |
| 4 · Change in ownership | Jan 25, 2023 | Insider trade | SEC |
| S-8 · Registration statement for employee plans | Dec 22, 2022 | Offer document | SEC |
| 8-K · Current report | Nov 30, 2022 | Meeting outcome | SEC |
| 8-K · Current report | Nov 15, 2022 | Results | SEC |
| 10-Q/A · Quarterly report, amended | Nov 14, 2022 | Quarterly report | SEC |
| 10-Q · Quarterly report | Nov 14, 2022 | Quarterly report | SEC |
| EFFECT · Notice that a registration is effective | Oct 21, 2022 | Other filings | SEC |
| POS AM · Amendment to an effective registration | Oct 14, 2022 | Offer document | SEC |
| DEFA14A · Additional proxy material | Oct 12, 2022 | Meeting notice | SEC |
| DEF 14A · Proxy statement | Oct 12, 2022 | Meeting notice | SEC |
| PRE 14A · Preliminary proxy statement | Sep 30, 2022 | Meeting notice | SEC |
| 8-K · Current report | Aug 15, 2022 | Results | SEC |
| 10-Q · Quarterly report | Aug 12, 2022 | Quarterly report | SEC |
| 8-K · Current report | Jul 28, 2022 | Current report | SEC |
| 8-K · Current report | Jun 24, 2022 | Current report | SEC |
| 10-Q · Quarterly report | May 16, 2022 | Quarterly report | SEC |
| 8-K · Current report | Apr 26, 2022 | Current report | SEC |
| 4 · Change in ownership | Apr 11, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Apr 11, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Apr 11, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Apr 11, 2022 | Insider trade | SEC |
| 8-K · Current report | Apr 4, 2022 | Results | SEC |
| 8-K/A · Current report, amended | Apr 1, 2022 | Meeting outcome | SEC |
| 10-K · Annual report | Mar 31, 2022 | Annual report | SEC |
| 8-K · Current report | Mar 4, 2022 | Management or board change | SEC |
| SC 13D/A · Big-stake notice, amended | Feb 28, 2022 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 23, 2022 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 11, 2022 | Big-stake notice | SEC |
| SC 13G/A · Big-stake notice, amended | Feb 10, 2022 | Big-stake notice | SEC |
| 8-K · Current report | Jan 24, 2022 | Material contract | SEC |
| 8-K · Current report | Jan 21, 2022 | Material contract | SEC |
| EFFECT · Notice that a registration is effective | Jan 18, 2022 | Other filings | SEC |
| 424B3 · Prospectus | Jan 14, 2022 | Offer document | SEC |
| CORRESP · Letter to the SEC | Jan 12, 2022 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Jan 12, 2022 | Other filings | SEC |
| CORRESP · Letter to the SEC | Jan 12, 2022 | Other filings | SEC |
| 4 · Change in ownership | Jan 7, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 7, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 7, 2022 | Insider trade | SEC |
| 4 · Change in ownership | Jan 7, 2022 | Insider trade | SEC |
| S-1 · Registration statement | Jan 6, 2022 | Offer document | SEC |
| D | Jan 3, 2022 | Other filings | SEC |
| 4 · Change in ownership | Jan 3, 2022 | Insider trade | SEC |
| 8-K · Current report | Dec 27, 2021 | Material contract | SEC |
| 424B5 · Prospectus | Dec 23, 2021 | Offer document | SEC |
| 8-K · Current report | Dec 23, 2021 | Management or board change | SEC |
| 424B3 · Prospectus | Dec 20, 2021 | Offer document | SEC |
| EFFECT · Notice that a registration is effective | Dec 20, 2021 | Other filings | SEC |
| CORRESP · Letter to the SEC | Dec 15, 2021 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Dec 15, 2021 | Other filings | SEC |
| S-1 · Registration statement | Dec 13, 2021 | Offer document | SEC |
| D | Dec 3, 2021 | Other filings | SEC |
| 8-K · Current report | Dec 1, 2021 | Material contract | SEC |
| 424B5 · Prospectus | Dec 1, 2021 | Offer document | SEC |
| 4 · Change in ownership | Nov 30, 2021 | Insider trade | SEC |
| EFFECT · Notice that a registration is effective | Nov 24, 2021 | Other filings | SEC |
| 424B3 · Prospectus | Nov 23, 2021 | Offer document | SEC |
| CORRESP · Letter to the SEC | Nov 23, 2021 | Other filings | SEC |
| DEF 14A · Proxy statement | Nov 22, 2021 | Meeting notice | SEC |
| CORRESP · Letter to the SEC | Nov 22, 2021 | Other filings | SEC |
| UPLOAD · Letter from the SEC | Nov 19, 2021 | Other filings | SEC |
| 8-K · Current report | Nov 17, 2021 | Current report | SEC |
| 8-K · Current report | Nov 15, 2021 | Results | SEC |
| 10-Q · Quarterly report | Nov 15, 2021 | Quarterly report | SEC |
| S-1 · Registration statement | Nov 12, 2021 | Offer document | SEC |
| SC 13G · Big-stake notice | Oct 27, 2021 | Big-stake notice | SEC |
| D | Oct 26, 2021 | Other filings | SEC |
| SC 13G · Big-stake notice | Oct 22, 2021 | Big-stake notice | SEC |
| 4 · Change in ownership | Oct 21, 2021 | Insider trade | SEC |
| 4 · Change in ownership | Oct 20, 2021 | Insider trade | SEC |
| SC 13D/A · Big-stake notice, amended | Oct 20, 2021 | Big-stake notice | SEC |
| 8-K · Current report | Oct 15, 2021 | Material contract | SEC |
This page holds 200 of 257 filings. Open Filings
Cap table
Built by 6ix from Petros Pharmaceuticals Inc’s releases · as of Aug 15, 2026
- Common shares
- 42,372,260
- Fully diluted
- 42,372,260
Fully diluted
| Line | Shares | As of |
|---|---|---|
| Common shares | 42,372,260 | Aug 15, 2026 |
Share count over time
| Count | Shares |
|---|---|
| Aug 15, 2026 | 42,372,260 |
People
6ix reads each seat by machine from the page it links to, and can misread one.
| Person | Seat |
|---|---|
| Joshua N. Silverman Other companies: Femasys Inc. (Director · Since at least Nov 21, 2023); PharmaCyte Biotech, Inc. (Interim Chief Executive Officer, President, and Director · Since at least Aug 15, 2022); TAO Synergies Inc. (Executive Chairman · Since at least Jun 4, 2021); Q/C Technologies, Inc. (Executive Chairman · Since at least Sep 6, 2018); Fabric.AI, Inc. (Chief Executive Officer, Director · Since at least Aug 15, 2016); Marker Therapeutics, Inc. (Director · Nov 28, 2016 – Oct 16, 2018 · Past); Neurotrope Inc (Director · Aug 4, 2016 – Dec 1, 2020 · Past); Protagenic Therapeutics, Inc. (Director · Feb 12, 2016 – Feb 21, 2020 · Past); MGT Capital Investments, Inc. (Director · Dec 31, 2015 – Dec 31, 2015 · Past); National Holdings Corporation (Director · Jul 28, 2014 – Sep 12, 2016 · Past) | Vice-Chairman of the Board · Since at least Dec 1, 2020 |
| Bruce Bernstein Other companies: RRE Ventures Acquisition Corp. (Director · Since at least Mar 2, 2026); Q/C Technologies, Inc. (Director · Since at least Sep 1, 2025); Wrap Technologies, Inc. (Director · Since at least Apr 21, 2023); TAO Synergies Inc. (Vice Chairman · Since at least Jun 4, 2021); XWELL, Inc. (Chairman of the Board · Since at least Feb 8, 2016); Neurotrope Inc (Director · Nov 14, 2016 – Dec 1, 2020 · Past) | Board of Directors · Since at least Dec 1, 2020 |
| Robert Weinstein Other companies: PharmaCyte Biotech, Inc. (Director · Since at least Nov 14, 2022); TAO Synergies Inc. (Chief Financial Officer · Since at least Jun 4, 2021); XWELL, Inc. (Director & Chair of Audit Committee · Since at least Feb 3, 2020); TaoWeave, Inc. (Director · May 29, 2023 – May 29, 2023 · Past); Neurotrope Inc (See Remarks · Nov 13, 2015 – Dec 1, 2020 · Past) | Chief Accounting Officer · Since at least Jun 18, 2026 |
| Wayne Walker Other companies: Pitney Bowes Inc. (Board Member · Since at least Sep 12, 2025); PharmaCyte Biotech, Inc. (Director · Since at least Dec 28, 2022); Outdoor Holding Company (Director · Since at least Nov 3, 2022); Fabric.AI, Inc. (Director · Since at least Dec 17, 2020); Wrap Technologies, Inc. (Director · Nov 14, 2018 – Jul 7, 2023 · Past) | Board of Directors · Since at least Dec 1, 2020 |
| John Shulman Other companies: Wrap Technologies, Inc. (Director · Since at least Oct 25, 2025); Allied Capital Corp (Managing Director · Mar 24, 2006 – Dec 4, 2008 · Past) | Director · Dec 1, 2020 – Dec 22, 2021 · Past |
| Andrew Gesek | President, Timm Medical · Dec 1, 2020 – May 11, 2021 · Past |
| Fady Boctor | See Remarks · Since at least Dec 1, 2020 |
| Greg Bradley | Director · Dec 1, 2020 – Dec 21, 2023 · Past |
| Keith Lavan | Chief Financial Officer · Dec 1, 2020 – Dec 1, 2020 · Past |
| Mitchell Arnold | See Remarks · Jan 19, 2020 – Feb 19, 2025 · Past |
Log in to ask 6ix AI your own questions about Petros Pharmaceuticals Inc.